Unaudited Condensed Consolidated Statements of Stockholders’ Equity - USD ($)	Common Stock	Additional Paid in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit	Total
Balance at Dec. 31, 2020	$ 22,535	$ 71,648,453	$ (51,538)	$ (34,279,648)	$ 37,339,802
Balance (in Shares) at Dec. 31, 2020	22,534,874
Sale of common stock, net of offering costs	$ 2,140	28,021,424			28,023,564
Sale of common stock, net of offering costs (in Shares)	2,140,000
Issuance of common stock for stock option exercises	$ 245	655,008			655,253
Issuance of common stock for stock option exercises (in Shares)	244,656
Issuance of common stock for warrant exercises	$ 444	179,768			180,212
Issuance of common stock for warrant exercises (in Shares)	444,751
Stock-based compensation		1,030,415			1,030,415
Foreign currency translation adjustment			(37,958)		(37,958)
Net loss				(7,654,575)	(7,654,575)
Balance at Mar. 31, 2021	$ 25,364	101,535,068	(89,496)	(41,934,223)	59,536,713
Balance (in Shares) at Mar. 31, 2021	25,364,281
Balance at Dec. 31, 2020	$ 22,535	71,648,453	(51,538)	(34,279,648)	37,339,802
Balance (in Shares) at Dec. 31, 2020	22,534,874
Net loss					(12,310,287)
Balance at Jun. 30, 2021	$ 25,372	102,301,550	(116,830)	(46,589,935)	55,620,157
Balance (in Shares) at Jun. 30, 2021	25,371,781
Balance at Mar. 31, 2021	$ 25,364	101,535,068	(89,496)	(41,934,223)	59,536,713
Balance (in Shares) at Mar. 31, 2021	25,364,281
Additional offering costs related to the sale of common stock		(8,545)			(8,545)
Issuance of common stock for stock option exercises	$ 8	34,492			34,500
Issuance of common stock for stock option exercises (in Shares)	7,500
Stock-based compensation		740,535			740,535
Foreign currency translation adjustment			(27,334)		(27,334)
Net loss				(4,655,712)	(4,655,712)
Balance at Jun. 30, 2021	$ 25,372	102,301,550	(116,830)	(46,589,935)	55,620,157
Balance (in Shares) at Jun. 30, 2021	25,371,781
Balance at Dec. 31, 2021	$ 25,372	104,078,968	(48,921)	(65,318,360)	38,737,059
Balance (in Shares) at Dec. 31, 2021	25,371,781
Stock-based compensation		1,177,702			1,177,702
Foreign currency translation adjustment			47,234		47,234
Net loss				(8,376,002)	(8,376,002)
Balance at Mar. 31, 2022	$ 25,372	105,256,670	(1,687)	(73,694,362)	31,585,993
Balance (in Shares) at Mar. 31, 2022	25,371,781
Balance at Dec. 31, 2021	$ 25,372	104,078,968	(48,921)	(65,318,360)	38,737,059
Balance (in Shares) at Dec. 31, 2021	25,371,781
Net loss					(17,122,327)
Balance at Jun. 30, 2022	$ 25,374	106,461,934	(107,121)	(82,440,687)	23,939,500
Balance (in Shares) at Jun. 30, 2022	25,373,818
Balance at Mar. 31, 2022	$ 25,372	105,256,670	(1,687)	(73,694,362)	31,585,993
Balance (in Shares) at Mar. 31, 2022	25,371,781
Issuance of common stock for stock option exercises	$ 2	10,183			10,185
Issuance of common stock for stock option exercises (in Shares)	2,037
Stock-based compensation		1,195,081			1,195,081
Foreign currency translation adjustment			(105,434)		(105,434)
Net loss				(8,746,325)	(8,746,325)
Balance at Jun. 30, 2022	$ 25,374	$ 106,461,934	$ (107,121)	$ (82,440,687)	$ 23,939,500
Balance (in Shares) at Jun. 30, 2022	25,373,818